|
Beta Drugs Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
1658.43 Cr.
|
P/BV
|
9.17
|
Book Value (Rs.)
|
179.17
|
|
52 Week High/Low (Rs.)
|
2170/1429
|
FV/ML
|
10/1
|
P/E(X)
|
39.10
|
|
Bookclosure
|
26/03/2025
|
EPS (Rs.)
|
42.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 61.54 | 48.75 | 41.06 | 34.30 | 15.95 |
| | | | | | |
| Net CashFlow From Operating Activities | 36.14 | 30.93 | 23.38 | 29.63 | 18.60 |
| Net Cash Used In Investing Activities | -35.72 | -13.97 | -19.07 | -21.75 | -5.85 |
| Net Cash Used From Financing Activities | 117.97 | -7.49 | -2.47 | -0.97 | -7.71 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 118.39 | 9.47 | 1.84 | 6.90 | 5.04 |
| Cash And Cash Equivalents Begin of Year | 28.63 | 19.16 | 17.32 | 10.42 | 5.39 |
| Cash And Cash Equivalents End Of Year | 147.02 | 28.63 | 19.16 | 17.32 | 10.42 |